M. Planker
Impact in
- Gastroenterology top 5%
- Gastrointestinal Tumor Research and Treatment
- Oncology top 10%
- Colorectal Cancer Treatments and Studies
- Viral-associated cancers and disorders
Papers in
-
- Acute Myeloid Leukemia Research 4
- Genetics 5
- Chronic Lymphocytic Leukemia Research 5
- Co-authors
- B Paillot (1 shared paper)Ángel J. Lacave (1 shared paper)H. Bodenstein (1 shared paper)Philippe Rougier (1 shared paper)Eric Van Cutsem (1 shared paper)Michel Ducreux (1 shared paper)Benoît Baron (1 shared paper)H. Wilke (1 shared paper)
- Journals
- Blood (3 papers)Journal of Clinical Oncology (3 papers)Journal of Molecular Medicine (1 paper)Cancer (1 paper)European Journal of Cancer (1 paper)
- Partner nations
- GermanyAustraliaUnited States
In The Last Decade
M. Planker
18 papers receiving 720 citations
Peers
Comparison fields: 5 of 48
- Gastroenterology 90
- Oncology 344
- Pulmonary and Respiratory Medicine 390
- Pathology and Forensic Medicine 148
- Hematology 67
Countries citing papers authored by M. Planker
This map shows the geographic impact of M. Planker's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by M. Planker with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites M. Planker more than expected).
Fields of papers citing papers by M. Planker
This network shows the impact of papers produced by M. Planker. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by M. Planker. The network helps show where M. Planker may publish in the future.
Co-authors
The 25 scholars most cited alongside M. Planker, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
| # | Work | ||
|---|---|---|---|
| 1 | 2000 | 457 | |
| 2 | 2012 | 77 | |
| 3 | High-dose cytosine arabinoside in combination with mitoxantrone for the treatment of refractory acute myeloid and lymphoblastic leukemia. | 1987 | 41 |
| 4 | Treatment of refractory acute lymphoblastic leukemia in adults with high dose cytosine arabinoside and mitoxantrone (HAM). | 1990 | 30 |
| 5 | 2012 | 25 | |
| 6 | Synchronous double primary malignant lymphoma of low grade malignancy and early cancer (collision tumor) of the stomach. | 1984 | 24 |
| 7 | 2004 | 20 | |
| 8 | 2006 | 20 | |
| 9 | 1992 | 16 | |
| 10 | 2008 | 15 | |
| 11 | 1996 | 15 | |
| 12 | 2005 | 6 | |
| 13 | 1992 | 3 | |
| 14 | 1983 | 2 | |
| 15 | 2009 | 1 | |
| 16 | 2023 | 1 | |
| 17 | 1986 | 1 | |
| 18 | 1996 | 1 |
About M. Planker
M. Planker is a scholar working on Hematology, Genetics, Pathology and Forensic Medicine, Oncology and Pulmonary and Respiratory Medicine, having authored 18 papers that have together received 755 indexed citations. Recurring topics across this work include Lymphoma Diagnosis and Treatment (5 papers), Chronic Lymphocytic Leukemia Research (5 papers), Acute Myeloid Leukemia Research (4 papers), Viral-associated cancers and disorders (3 papers), Acute Lymphoblastic Leukemia research (3 papers), Cutaneous lymphoproliferative disorders research (2 papers), Renal cell carcinoma treatment (1 paper) and Nanoparticle-Based Drug Delivery (1 paper). The work is most often cited by research in Gastroenterology (90 citations), Oncology (344 citations), Pulmonary and Respiratory Medicine (390 citations), Pathology and Forensic Medicine (148 citations) and Hematology (67 citations). M. Planker has collaborated with scholars based in Germany, Australia and United States. Frequent co-authors include B Paillot, Ángel J. Lacave, H. Bodenstein, Philippe Rougier, Eric Van Cutsem, Michel Ducreux, Benoît Baron, H. Wilke, Harry Bleiberg and J. Wils. Their work appears in journals such as Blood, Journal of Clinical Oncology, Journal of Molecular Medicine, Cancer and European Journal of Cancer.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.